Interestingly, recent transcriptomic and proteomic analysis of breast cancer models showed that DEX-mediated GR signaling activation promoted metastasis by upregulating the non-canonical Wnt pathway highlighted by ROR1 (receptor tyrosine kinase-like orphan receptor) expression while decreasing the efficacy of paclitaxel9. Here, NR3C1 is linked to breast cancer.